More Physiological Cell-Based Assays for HCS
Location: France, Auvergne-Rhône-Alpes, Grenoble
Employees: 11-50
Total raised: $14.7M
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | North Shor... | nsiv.org |
| - | Auriga Par... | auriga.vc |
| - | Entreprene... | entreprene... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.11.2011 | Series C | $10M | - |
| 30.09.2009 | - | $4.7M | Auriga Par... |
Mentions in press and media 3
| Date | Title | Description |
| 28.11.2011 | CYTOO Seals $10M Series C | Company that specializes in cell-based assays, announced today the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lew... |
| 28.11.2011 | CYTOO Completes $10M Series C Funding | CYTOO SA, a Grenoble, France-based company specializing in cell-based assays, has completed a $10m (€7m) Series C funding. The round was led by Sham and Entrepreneurs Fund, with participation from existing investors AURIGA Partners and Jacq... |
| 30.09.2009 | French Cytoo Raises $4.7M in Financing Round Led by Auriga Partners | CYTOO SA., a provider of technologies and products for high content cell analysis, closed its second funding round of $4.7m (approximately €3.2m) led by new investor Auriga Partners. Jacques Lewiner, co-founder and president of the supervis... |